Table 4.
Multivariate analysis of significant clinicopathological variables regarding OS in the whole cohort and in the lymph node-negative and lymph node-positive BC.
| p Value | Hazard Ratio | |||||
|---|---|---|---|---|---|---|
| Whole Cohort | Lymph Node-Negative | Lymph Node-Positive | Whole Cohort | Lymph Node-Negative | Lymph Node-Positive | |
| Age | 0.000154 *** | 0.004 ** | 0.002 ** | 1.033 | 1.041 | 1.039 |
| Tumor size | 0.000001 *** | 0.061 | 0.005 ** | 1.479 | 1.345 | 1.348 |
| ER | 0.032 * | 0.064 | 0.043 * | 0.586 | 0.501 | 0.489 |
| HER2 | 0.026 * | 0.776 | 0.001 ** | 1.917 | 0.855 | 3.441 |
| Total AhR | 0.571 | 0.046* | 0.454 | 1.164 | 3.369 | 0.788 |
Correlations were statistically significant for p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***).